The New Emerald Fields Cannaboutique to Host a Grand Opening June 4, 2022 in the Former Urban Wellness Location

DENVER , June 2, 2022 /CNW/ - Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) a premier vertically integrated, multi-state operating cannabis company with assets in Colorado and New Mexico , announces the grand opening of its adult-use cannaboutique, Emerald Fields, formally known as Urban Health & Wellness Inc. (Urban Wellness) located in the Highlands neighborhood of Denver, Colorado . Emerald Fields provides a boutique cannabis shopping experience, with additional locations in Manitou Springs and Cherry Creek .

Schwazze kicks off the grand opening celebration on Saturday, June 4, 2022 at 10 am , with additional events occurring at various Schwazze-owned retailers throughout the month of June. The celebration will feature swag bags for the first 50 shoppers, donuts & coffee, games, a lunchtime taco food truck, social media scavenger hunt, and representatives from various prominent cannabis brands such as: O.Pen, Wyld, Ripple, Stratos and Green Dot. In addition, Emerald Fields Highlands will offer all-weekend, in-store discounts including 25% off all new products and $10.99 eighths of flower. Shoppers also receive a house pre-roll for $1 with a minimum, pre-tax purchase of $60 .

"Our team is delighted to open the Emerald Fields Highlands cannaboutique, and to introduce customers to a distinctly different, enjoyable way of shopping," said Collin Lodge , Vice President - Retail for Schwazze. "Our Emerald Fields Cannaboutiques offer an incredible selection of products, great service, and an educated and engaged staff that make it easy for shoppers to find what they're looking for. We're thrilled to become a part of The Highlands community and look forward to introducing everyone to the Emerald Fields boutique cannabis shopping experience."

The dispensary, located at 2675 W. 38th Ave. Denver, CO , plans to undergo remodeling this summer following the acquisition of Urban Health & Wellness Inc., by Schwazze in May 2022 . The acquisition and rebrand under the Emerald Fields name are part of an aggressive expansion in Colorado by Schwazze, which has grown the total number of Colorado dispensaries to 23 along with four cultivation facilities.

Emerald Fields Highlands 2675 W 38th Ave, Denver, CO 80211

Grand Reopening Celebration June 4, 2022 10 am

Since April 2020 , Schwazze has acquired or announced the planned acquisition of 33 cannabis dispensaries as well as seven cultivation facilities and two manufacturing assets in Colorado and New Mexico . In May 2021 , Schwazze announced its BioSciences division and in August 2021 , it commenced home delivery services in Colorado .

Schwazze (OTCQX:SHWZ, NEO:SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company's leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.

Medicine Man Technologies, Inc. was Schwazze's former operating trade name.  The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

This press release contains "forward-looking statements." Such statements may be preceded by the words "plan," "will," "may,", "predicts," or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws, and * out ability to satisfy the closing conditions for the private finding described in this press release. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/schwazze-announces-grand-opening-of-emerald-fields-dispensary-in-denvers-highlands-neighborhood-301560099.html

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/02/c6645.html

Bridgewater’s co–chief investment officer said the U.S. economy could slow down further.

Spirit Airlines Inc's acquisition by JetBlue Airways Corp has become a "growing probability", according to analysts at JPMorgan. Florida-based ultra-low-cost carrier Spirit is the subject of a bidding war between JetBlue and Frontier Group Holdings Inc. Both bidders view Spirit as an opportunity to expand their domestic footprints at a time when the U.S. airline industry is dogged by persistent labor and aircraft shortages.

The U.S. hasn't yet entered a recession -- which is officially defined as two consecutive quarters of negative GDP growth -- but runaway inflation, stagnant wages, food shortages, rising interest rates, and geopolitical turmoil could all break this fragile economy's back in the near future. If that happens, growth stocks will fall further as value stocks become even more attractive. Altria is the top tobacco company in America.

Yahoo Finance Live’s Brian Sozzi, Brad Smith, and Julie Hyman discuss quarterly earnings for DocuSign.

Shares of several major bank stocks took a hit today after new data showed that inflation is still surging and may not have peaked yet. The Dow Jones Industrial Average had lost more than 650 points as of this writing while the Nasdaq Composite was down close to 3%. Shares of Citigroup (NYSE: C) traded 4.3% lower as of 2:25 p.m. ET today, shares of JPMorgan Chase (NYSE: JPM) were 4.2% lower, and shares of Goldman Sachs (NYSE: GS) were down 4.8%.

(Bloomberg) -- Former Treasury Secretary Lawrence Summers said the Federal Reserve has failed to account for its mistakes and to realize the damage to its credibility after the latest inflation data dashed hopes that a peak had been reached.Most Read from BloombergUS Lifts Covid-19 Test Requirement for International TravelUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot He

Yahoo Finance's Brian Cheung and Jared Blikre join the Live show to break down the market sell-off resulting from today's CPI data, the impact of inflation on energy commodities, and the bond market.

In this article, we discuss 10 beaten-down Asian stocks to buy today. If you want to see more stocks in this selection, click 5 Beaten-Down Asian Stocks to Buy Today. While the US dollar remains strong, Asian markets on June 10 stumbled on the back of higher rates guidance from the European Central Bank and […]

Since taking the reins as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965, Warren Buffett has put on a moneymaking clinic for Wall Street. While there are no shortage of reasons for the Oracle of Omaha's sustained success, his love of dividend stocks could be the most important component. Dividend stocks are almost always profitable and time-tested.

(Bloomberg) -- When the nineties ended, an overvalued stock market took three long years to rid itself of its accumulated excess in what is now known as the dot-com crash.Most Read from BloombergUS Lifts Covid-19 Test Requirement for International TravelUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot HearingStocks Reel, Bond Yields Surge on Inflation Angst: Markets WrapTh

ChargePoint, Autoliv, and QuantumScape look like excellent long-term bets, despite the near-term headwinds they face.

Moderna's (NASDAQ: MRNA) stock is in poor shape. Unfortunately, when investors take a closer look at why Moderna's stock is so inexpensive, they probably won't want to make that purchase. The most obvious reason Moderna's stock is so cheap is that the market (and public) have moved beyond buying shares of heavily hyped vaccine stocks.

“Ball of confusion, that's what the world is today,” sang the Temptations on their 1970 classic, a sentiment which can readily apply to the stock market’s present state. It’s hard to get a grip on the market’s choppy action in 2022 and investors could use a clear signal to follow when considering a new investment. One way to get a head start is by tracking the moves of the insiders. These are the corporate officers with in-depth knowledge of the companies they helm. To keep the playing field lev

Friday’s consumer-price index report for May — which showed the annual headline U.S. inflation rate climbing to 8.6% in May, with few signs of having peaked — is boosting the chances of a jumbo-sized rate increase by monetary-policy makers as soon as next week, and eliciting dire warnings that central bankers have completely lost control of prices. Fed funds futures traders now see a 21% chance of a 75-basis-point hike in June, up from just 3.6% on Thursday, according to the CME FedWatch Tool. Beneath the issue of where the Fed goes from here is a much more fundamental and serious problem: Some observers fear the U.S. central bank has already effectively lost control of inflation.

Be greedy (but selective) when others are fearful.

Inflation remains white-hot. These stocks can help stop the pain.

The bears have killed Carvana's share price this year, but don't be surprised if its stock gets back on the road to growth.

In this article, we discuss the 10 safe blue chip stocks to buy in June. If you want to skip our detailed analysis of the current market situation and blue chip stocks, go directly to 5 Safe Blue Chip Stocks to Buy in June. Inflation is eating away at the purchasing power of consumers across the […]

AMD painted a bright picture of its growing market opportunity, especially in data centers, at an analyst day presentation.

Markets are volatile. Use these dividend stocks for peace of mind.